β-Catenin Signaling Regulates the


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
27 09 2021
Historique:
pubmed: 29 7 2021
medline: 29 3 2022
entrez: 28 7 2021
Statut: ppublish

Résumé

β-Catenin (Ctnnb1) supports high levels of liver gene expression in hepatocytes in proximity to the central vein functionally defining zone 3 of the liver lobule. This region of the liver lobule supports the highest levels of viral biosynthesis in wild-type hepatitis B virus (HBV) transgenic mice. Liver-specific β-catenin-null HBV transgenic mice exhibit a stark loss of high levels of pericentral viral biosynthesis. Additionally, viral replication that does not depend directly on β-catenin activity appears to expand to include hepatocytes of zone 1 of the liver lobule in proximity to the portal vein, a region of the liver that typically lacks significant HBV biosynthesis in wild-type HBV transgenic mice. While the average amount of viral RNA transcripts does not change, viral DNA replication is reduced approximately 3-fold. Together, these observations demonstrate that β-catenin signaling represents a major determinant of HBV biosynthesis governing the magnitude and distribution of viral replication across the liver lobule

Identifiants

pubmed: 34319157
doi: 10.1128/JVI.00780-21
pmc: PMC8475508
doi:

Substances chimiques

CTNNB1 protein, human 0
DNA, Viral 0
RNA, Viral 0
beta Catenin 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0078021

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI125401
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA238328
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002003
Pays : United States
Organisme : HHS | NIH | National Center for Advancing Translational Sciences (NCATS)
ID : UL1TR002003

Références

Proc Natl Acad Sci U S A. 1996 May 14;93(10):4589-94
pubmed: 8643448
J Biol Chem. 1999 Jan 1;274(1):305-15
pubmed: 9867845
N Engl J Med. 2008 Oct 2;359(14):1486-500
pubmed: 18832247
Nature. 1985 Oct 10-16;317(6037):489-95
pubmed: 2995835
J Virol. 2000 Feb;74(3):1241-51
pubmed: 10627534
J Virol. 1999 Dec;73(12):10377-86
pubmed: 10559356
J Virol. 2013 Jan;87(2):991-7
pubmed: 23135717
Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1310-5
pubmed: 12552098
Cell. 1982 Jun;29(2):403-15
pubmed: 6180831
Oncogene. 2002 Nov 28;21(54):8293-301
pubmed: 12447692
Bull World Health Organ. 1975;52(3):293-300
pubmed: 1084799
Genesis. 2004 Jul;39(3):167-72
pubmed: 15282742
Nature. 1979 Oct 25;281(5733):646-50
pubmed: 399327
Cell. 1996 Aug 9;86(3):391-9
pubmed: 8756721
Mol Cell. 2000 Sep;6(3):507-15
pubmed: 11030331
Virology. 2019 Jan 2;526:214-221
pubmed: 30419515
Biochem Biophys Res Commun. 2009 Apr 17;381(4):544-8
pubmed: 19233123
Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1841-6
pubmed: 11172038
Am J Pathol. 2010 Feb;176(2):744-53
pubmed: 20019186
J Biol Chem. 2012 Jun 29;287(27):22683-90
pubmed: 22589536
Science. 1999 May 21;284(5418):1362-5
pubmed: 10334992
J Virol. 1987 Mar;61(3):683-92
pubmed: 3543403
J Virol. 1995 Oct;69(10):6158-69
pubmed: 7666518
J Virol. 2012 Mar;86(5):2760-8
pubmed: 22171277
J Biol Chem. 1998 Oct 30;273(44):29022-31
pubmed: 9786908
Hepatology. 2007 May;45(5):1298-305
pubmed: 17464972
J Virol. 2017 Sep 27;91(20):
pubmed: 28768874
Gene. 1990 Jul 16;91(2):185-91
pubmed: 2145197
Mol Cell Biol. 1995 Jun;15(6):3012-22
pubmed: 7539101
Carcinogenesis. 2005 Jan;26(1):239-48
pubmed: 15471898
J Virol. 1997 Feb;71(2):1058-71
pubmed: 8995626
J Virol. 1990 May;64(5):2360-8
pubmed: 2157890
Bioinformatics. 2021 Jun 16;37(10):1485-1487
pubmed: 32997742
J Virol. 1987 Mar;61(3):904-11
pubmed: 3806799
J Virol. 2005 Sep;79(17):11045-52
pubmed: 16103155
Proc Natl Acad Sci U S A. 1988 Aug;85(15):5525-9
pubmed: 2840665
Mol Cell. 2004 Aug 27;15(4):499-509
pubmed: 15327767
J Virol. 2009 Oct;83(19):9652-62
pubmed: 19625407
J Virol. 1994 Mar;68(3):1265-70
pubmed: 8107192
N Engl J Med. 1995 Apr 20;332(16):1092-3
pubmed: 7898530
Science. 1999 May 21;284(5418):1365-8
pubmed: 10334993
Int J Biochem Cell Biol. 2011 Feb;43(2):230-7
pubmed: 19941970
J Virol. 2000 Jun;74(11):5032-9
pubmed: 10799577
Immunity. 1996 Jan;4(1):25-36
pubmed: 8574849
Oncogene. 2006 Dec 4;25(57):7482-91
pubmed: 17143292
EMBO J. 2012 Jun 13;31(12):2714-36
pubmed: 22617422
Nature. 1996 Aug 15;382(6592):638-42
pubmed: 8757136
Hepatology. 2010 Oct;52(4):1410-9
pubmed: 20722001
Anal Quant Cytol Histol. 2001 Aug;23(4):291-9
pubmed: 11531144
Hepatology. 2006 Apr;43(4):817-25
pubmed: 16557553
Development. 2001 Apr;128(8):1253-64
pubmed: 11262227
Nature. 2015 Aug 13;524(7564):180-5
pubmed: 26245375
Science. 2005 May 20;308(5725):1181-4
pubmed: 15905404
Mol Cell. 2000 Sep;6(3):517-26
pubmed: 11030332
Anal Biochem. 1987 Apr;162(1):156-9
pubmed: 2440339

Auteurs

Grant Tarnow (G)

Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicagogrid.185648.6, Chicago, Illinois, USA.

Alan McLachlan (A)

Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicagogrid.185648.6, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH